U.S. Capital Wealth Advisors, LLC Moderna, Inc. Transaction History

U.S. Capital Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$96.41 - $126.61 $760,964 - $999,332	7,893 Added 52.04%	23,061 $2.38 Million
Q2 2023 Aug 04, 2023	BUY	$118.5 - $160.53 $1.2 Million - $1.63 Million	10,155 Added 202.57%	15,168 $1.84 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $298,316 - $433,246	2,199 Added 78.14%	5,013 $769,000
Q4 2022 Feb 03, 2023	SELL	$118.38 - $210.04 $65,109 - $115,522	-550 Reduced 16.35%	2,814 $505,000
Q3 2022 Nov 01, 2022	BUY	$118.07 - $194.18 $29,517 - $48,545	250 Added 8.03%	3,364 $398,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $19,209 - $28,960	-164 Reduced 5.0%	3,114 $445,000
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $414,535 - $770,493	3,278 New	3,278 $565,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.